Citations

Citations to this article as recorded by  

• Advanced Endoscopic Imaging for Assessing Mucosal Healing and Histologic Remission in Inflammatory Bowel Diseases
  Tommaso Pessarelli, Gian Eugenio Tontini, Helmut Neumann
  Gastrointestinal Endoscopy Clinics of North America.2025; 35(1): 159.     CrossRef
• Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis
  Michael Youssef, Kelly Dong, So Jeong Lee, Neeraj Narula
  Inflammatory Bowel Diseases.2024; 30(1): 125.     CrossRef
• Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
  Mohammad Shehab, Sahad Al Akram, Amro Hassan, Fatema Alrashed, Vipul Jairath, Talat Bessissow
  Inflammatory Bowel Diseases.2024; 30(4): 563.     CrossRef
• Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus
  Ferdinando D’Amico, Fernando Magro, Britta Siegmund, Taku Kobayashi, Paulo Gustavo Kotze, Virginia Solitano, Benedicte Caron, Sameer Al Awadhi, Ailsa Hart, Vipul Jairath, Axel Dignass, Laurent Peyrin-Biroulet, Silvio Danese
  Inflammatory Bowel Diseases.2024; 30(6): 1009.     CrossRef
• Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib
  Sara van Gennep, Ivan C N Fung, Djuna C de Jong, Rishand K Ramkisoen, Esmé Clasquin, Jitteke de Jong, Leonie C S de Vries, Wouter J de Jonge, Krisztina B Gecse, Mark Löwenberg, John C Woolcott, Aart Mookhoek, Geert R D’Haens
  Journal of Crohn's and Colitis.2024; 18(8): 1283.     CrossRef
• Etrolizumab as an induction and maintenance therapy for ulcerative colitis: A systematic review and meta‐analysis of randomized controlled trials
  Othman Saleh, Mohamed T. Abuelazm, Islam Mohamed, Alaa Ramadan, Mohammad Assaf, Ahmad Alzoubi, Majd M. AlBarakat, Basel Abdelazeem
  JGH Open.2024;[Epub]     CrossRef
• Adequacy of sigmoidoscopy as compared to colonoscopy for assessment of disease activity in patients of ulcerative colitis: a prospective study
  Sameet Tariq Patel, Anuraag Jena, Sanjay Chandnani, Shubham Jain, Pankaj Nawghare, Saurabh Bansal, Harsh Gandhi, Rishikesh Malokar, Jay Chudasama, Prasanta Debnath, Seemily Kahmei, Rima Kamat, Sangeeta Kini, Qais Q Contractor, Pravin M Rathi
  Intestinal Research.2024; 22(3): 310.     CrossRef
• Deep mucosal healing in ulcerative colitis: how deep is better?
  Xin Jin, Yan You, Gechong Ruan, Weixun Zhou, Ji Li, Jingnan Li
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Histologic improvement predicts endoscopic remission in patients with ulcerative colitis
  Ji Eun Kim, Minjee Kim, Min-Ji Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Sang Yun Ha, Young-Ho Kim
  Scientific Reports.2024;[Epub]     CrossRef
• Epithelial neutrophil localization and tight junction Claudin‐2 expression are innovative outcome predictors in inflammatory bowel disease
  Irene Zammarchi, Giovanni Santacroce, Miguel Puga‐Tejada, Brian Hayes, Rory Crotty, Elaine O’Driscoll, Snehali Majumder, Wiktoria Kaczmarczyk, Yasuharu Maeda, Jane McCarthy, Kathleen Sugrue, Caitriona O’Sullivan, Louise Burke, Subrata Ghosh, Marietta Iacu
  United European Gastroenterology Journal.2024; 12(9): 1155.     CrossRef
• Predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis
  Arshdeep Singh, Arshia Bhardwaj, Riya Sharma, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Dharmatma Singh, Simranjeet Kaur, Devanshi Jain, Namita Bansal, Ramit Mahajan, Kirandeep Kaur, Aminder Singh, Vikram Narang, Harpreet Kaur, Vandana Midha, Ajit Sood
  Intestinal Research.2024;[Epub]     CrossRef
• Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study)
  Kristina A Holten, Tomm Bernklev, Randi Opheim, Bjørn C Olsen, Trond Espen Detlie, Vibeke Strande, Petr Ricanek, Raziye Boyar, May-Bente Bengtson, Tone B Aabrekk, Øyvind Asak, Svein Oskar Frigstad, Vendel A Kristensen, Milada Hagen, Magne Henriksen, Gert
  Journal of Crohn's and Colitis.2024;[Epub]     CrossRef
• Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1
  Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim
  Inflammatory Bowel Diseases.2023; 29(2): 238.     CrossRef
• (Re)Appraising Remission in Ulcerative Colitis
  Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Charles N Bernstein, David T Rubin
  Inflammatory Bowel Diseases.2023; 29(8): 1317.     CrossRef
• Artificial Intelligence Enables Quantitative Assessment of Ulcerative Colitis Histology
  Fedaa Najdawi, Kathleen Sucipto, Pratik Mistry, Stephanie Hennek, Christina K.B. Jayson, Mary Lin, Darren Fahy, Shawn Kinsey, Ilan Wapinski, Andrew H. Beck, Murray B. Resnick, Archit Khosla, Michael G. Drage
  Modern Pathology.2023; 36(6): 100124.     CrossRef
• Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease
  Stefan Chiriac, Catalin Victor Sfarti, Horia Minea, Carol Stanciu, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Tudor Cuciureanu, Oana Petrea, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia, Robert Nastasa, Remus Stafie, Adrian Rotaru, Er
  Diagnostics.2023; 13(7): 1230.     CrossRef
• HISTOPATHOLOGICAL FEATURES IN RELAPSE OF ULCERATIVE COLITIS.
  Saroash Iqbal, Aman Ur Rehman, Nausheen Henna, Zara Madiha, Sahar Moeed, Uzma Aslam
  JAIMC: Journal of Allama Iqbal Medical College.2023;[Epub]     CrossRef
• Mucosal Atrophy Predicts Poorer Outcomes in Pediatric Ulcerative Colitis—A National Inception Cohort Study
  Emily Stenke, Lorraine Stallard, Sarah Cooper, Anna Dominik, Abigail Pilkington, Sheila Sugrue, Maureen O’Sullivan, Michael McDermott, Shoana Quinn, Annemarie Broderick, Billy Bourke, Séamus Hussey
  Journal of Pediatric Gastroenterology & Nutrition.2023; 76(5): 603.     CrossRef
• Automating Ground Truth Annotations for Gland Segmentation Through Immunohistochemistry
  Tushar Kataria, Saradha Rajamani, Abdul Bari Ayubi, Mary Bronner, Jolanta Jedrzkiewicz, Beatrice S. Knudsen, Shireen Y. Elhabian
  Modern Pathology.2023; 36(12): 100331.     CrossRef
• Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing
  Alina Ecaterina Jucan, Otilia Gavrilescu, Mihaela Dranga, Iolanda Valentina Popa, Ioana-Ruxandra Mihai, Vasile-Claudiu Mihai, Gabriela Stefanescu, Vasile Liviu Drug, Cristina Cijevschi Prelipcean, Radu-Alexandru Vulpoi, Oana-Bogdana Barboi, Irina Ciortesc
  Biomedicines.2023; 11(11): 3090.     CrossRef
• Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease
  Barbara Sosna, David Aebisher, Angelika Myśliwiec, Klaudia Dynarowicz, Dorota Bartusik-Aebisher, Piotr Oleś, Grzegorz Cieślar, Aleksandra Kawczyk-Krupka
  International Journal of Molecular Sciences.2023; 25(1): 202.     CrossRef
• Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis
  Niels Vande Casteele, Jonathan A Leighton, Shabana F Pasha, Frank Cusimano, Aart Mookhoek, Catherine E Hagen, Christophe Rosty, Reetesh K Pai, Rish K Pai
  Inflammatory Bowel Diseases.2022; 28(4): 539.     CrossRef
• Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis
  Silvio Danese, Barrett G. Levesque, Brian G. Feagan, Alina Jucov, Bal Raj Bhandari, Rish K. Pai, Kristen Taylor Meadows, Brian J. Kirby, Jean‐Marie Bruey, Allan Olson, Robin Osterhout, Courtney Van Biene, Julia Ford, Richard Aranda, Kartik Raghupathi, Wil
  Alimentary Pharmacology & Therapeutics.2022; 55(4): 401.     CrossRef
• PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system
  Xianyong Gui, Alina Bazarova, Rocìo del Amor, Michael Vieth, Gert de Hertogh, Vincenzo Villanacci, Davide Zardo, Tommaso Lorenzo Parigi, Elin Synnøve Røyset, Uday N Shivaji, Melissa Anna Teresa Monica, Giulio Mandelli, Pradeep Bhandari, Silvio Danese, Jos
  Gut.2022; 71(5): 889.     CrossRef
• Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis
  Angelo Viscido, Marco Valvano, Gianpiero Stefanelli, Annalisa Capannolo, Chiara Castellini, Eugenia Onori, Antonio Ciccone, Filippo Vernia, Giovanni Latella
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Appendiceal Orifice Inflammation Is Associated with Lower Rate of Complete Endoscopic Remission in Patients with Ulcerative Colitis
  Chang Kyo Oh, Han Hee Lee, Jin Su Kim, Bo-In Lee, Young-Seok Cho
  Journal of Personalized Medicine.2022; 12(5): 748.     CrossRef
• ECCO Position on Harmonisation of Crohn’s Disease Mucosal Histopathology
  F Magro, J Sabino, F Rosini, M Tripathi, P Borralho, P Baldin, S Danese, A Driessen, I O Gordon, M Iacucci, N Noor, M Svrcek, L Peyrin-Biroulet, R Feakins
  Journal of Crohn's and Colitis.2022; 16(6): 876.     CrossRef
• Constrained multiple instance learning for ulcerative colitis prediction using histological images
  Rocío del Amor, Pablo Meseguer, Tommaso Lorenzo Parigi, Vincenzo Villanacci, Adrián Colomer, Laëtitia Launet, Alina Bazarova, Gian Eugenio Tontini, Raf Bisschops, Gert de Hertogh, Jose G. Ferraz, Martin Götz, Xianyong Gui, Bu’Hussain Hayee, Mark Lazarev,
  Computer Methods and Programs in Biomedicine.2022; 224: 107012.     CrossRef
• Ulcerative colitis: Impact of early disease clearance on long‐term outcomes ‐ A multicenter cohort study
  Ferdinando D’Amico, Gionata Fiorino, Virginia Solitano, Eugenia Massarini, Lucas Guillo, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Stefanos Bonovas, Fernando Magro, Laurent Peyrin‐Biroulet, Silvio Danese
  United European Gastroenterology Journal.2022; 10(7): 775.     CrossRef
• Efficacy and safety of ozanimod for ulcerative colitis (review)
  M. V. Shapina, A. V. Poletova, T. A. Baranova
  Koloproktologia.2022; 21(3): 119.     CrossRef
• Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission
  Jun Ohara, Tetsuo Nemoto, Yasuharu Maeda, Noriyuki Ogata, Shin-ei Kudo, Toshiko Yamochi
  Journal of Gastroenterology.2022; 57(12): 962.     CrossRef
• Clinical Predictors of Response to Faecal Microbiota Transplantation in Patients with Active Ulcerative Colitis
  Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Kirandeep Kaur, Dharmatma Singh, Namita Bansal, Khushdeep Dharni
  Journal of Crohn's and Colitis.2021; 15(2): 238.     CrossRef
• Therapeutic drug monitoring of anti‐tumour necrosis factor‐α agents in inflammatory bowel disease: Limits and improvements
  José María Giráldez‐Montero, Jaime Gonzalez‐Lopez, Manuel Campos‐Toimil, María Jesús Lamas‐Díaz
  British Journal of Clinical Pharmacology.2021; 87(5): 2216.     CrossRef
• Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy
  Fernando Magro, Catarina Alves, Joanne Lopes, Susana Lopes, Helena Tavares de Sousa, José Cotter, Vitor Macedo da Silva, Paula Lago, Ana Vieira, Mariana Brito, Maria A.M. Duarte, Francisco Portela, João P. Silva, Paula Ministro, Bruno Arroja, Liliana Carv
  Clinical Gastroenterology and Hepatology.2021; 19(12): 2567.     CrossRef
• Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
  Akshita Gupta, Amy Yu, Laurent Peyrin-Biroulet, Ashwin N. Ananthakrishnan
  Clinical Gastroenterology and Hepatology.2021; 19(9): 1800.     CrossRef
• Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
  Ludimilla dos Reis Malvão, Kalil Madi, Barbara Cathalá Esberard, Renata Fernandes de Amorim, Kelly dos Santos Silva, Katia Farias e Silva, Heitor Siffert Pereira de Souza, Ana Teresa Pugas Carvalho
  Medicine.2021; 100(3): e24058.     CrossRef
• Real-life evaluation of histologic scores for Ulcerative Colitis in remission
  Christian Børde Arkteg, Sveinung Wergeland Sørbye, Lene Buhl Riis, Stig Manfred Dalen, Jon Florholmen, Rasmus Goll, Valérie Pittet
  PLOS ONE.2021; 16(3): e0248224.     CrossRef
• Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study
  William J Sandborn, Brian G Feagan, Stephen Hanauer, Severine Vermeire, Subrata Ghosh, Wenzhong J Liu, AnnKatrin Petersen, Lorna Charles, Vivian Huang, Keith Usiskin, Douglas C Wolf, Geert D’Haens
  Journal of Crohn's and Colitis.2021; 15(7): 1120.     CrossRef
• Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
  Marietta Iacucci, Louisa Jeffery, Animesh Acharjee, Olga Maria Nardone, Davide Zardo, Samuel C L Smith, Alina Bazarova, Rosanna Cannatelli, Uday N Shivaji, John Williams, Georgios Gkoutos, Subrata Ghosh
  Inflammatory Bowel Diseases.2021; 27(11): 1719.     CrossRef
• Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease
  Samuel C. L. Smith, Carl Banbury, Davide Zardo, Rosanna Cannatelli, Olga M. Nardone, Uday N. Shivaji, Subrata Ghosh, Pola Goldberg Oppenheimer, Marietta Iacucci, Pradeep Dudeja
  PLOS ONE.2021; 16(6): e0252210.     CrossRef
• Accurate diagnosis of endoscopic mucosal healing in ulcerative colitis using deep learning and machine learning
  Tien-Yu Huang, Shan-Quan Zhan, Peng-Jen Chen, Chih-Wei Yang, Henry Horng-Shing Lu
  Journal of the Chinese Medical Association.2021; 84(7): 678.     CrossRef
• Is histological remission of ulcerative colitis achievable?
  Oleg V. Knyazev, Anna V. Kagramanova, Sergei G. Khomeriki, Asfold I. Parfenov
  Terapevticheskii arkhiv.2021; 93(8): 975.     CrossRef
• Current Trends in IBD—Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System
  Yunki Y Yau, Valerie C Wasinger, Robert P Hirten, Emil Chuang, Merodean Huntsman, Jack Stylli, Jeff Shimizu, Vijay Yajnik, Jeffrey Smith, Shaoying N Lee, Sharat Singh, Christopher Wahl, Rupert W Leong, Bruce E Sands
  Inflammatory Bowel Diseases.2021; 27(Supplement): S17.     CrossRef
• Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy
  Oleg V. Knyazev, Sergey G. Khomeriki, Аnna V. Kagramanova, Albina A. Lishchinskaya, Olga A. Smirnova, Karina K. Noskova, Asfold I. Parfenov
  Terapevticheskii arkhiv.2021; 93(12): 1435.     CrossRef
• Histologic Activity and Steroid Use History are Risk Factors of Clinical Relapse in Ulcerative Colitis with Endoscopic Remission
  Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• Relationship between Mayo endoscopic score and histological scores in ulcerative colitis: A prospective study
  Jimil Shah, Usha Dutta, Ashim Das, Vishal Sharma, Harshal Mandavdhare, Pankaj Sharma, Dimple Kalsi, Priyanka Popli, Rakesh Kochhar
  JGH Open.2020; 4(3): 382.     CrossRef
• Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis
  Rish K. Pai, Douglas J. Hartman, Claudia Ramos Rivers, Miguel Regueiro, Marc Schwartz, David G. Binion, Reetesh K. Pai
  Clinical Gastroenterology and Hepatology.2020; 18(11): 2510.     CrossRef
• Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
  Natsuki Ishida, Takahiro Miyazu, Ryosuke Takano, Satoshi Tamura, Shinya Tani, Takuma Kagami, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Hiroaki Miyajima, Ken Sugimoto
  BMC Gastroenterology.2020;[Epub]     CrossRef
• ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
  Fernando Magro, Glen Doherty, Laurent Peyrin-Biroulet, Magali Svrcek, Paula Borralho, Alissa Walsh, Fatima Carneiro, Francesca Rosini, Gert de Hertogh, Luc Biedermann, Lieven Pouillon, Michael Scharl, Monika Tripathi, Silvio Danese, Vincenzo Villanacci, R
  Journal of Crohn's and Colitis.2020; 14(11): 1503.     CrossRef
• Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment
  Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa
  European Journal of Gastroenterology & Hepatology.2020; 32(9): 1091.     CrossRef
• What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
  Jongbeom Shin, Sung Min Kong, Gyeol Seong, Young-Ho Kim
  International Journal of Colorectal Disease.2020; 35(12): 2249.     CrossRef
• Treat to target or ‘treat to clear’ in inflammatory bowel diseases: one step further?
  Arianna Dal Buono, Giulia Roda, Marjorie Argollo, Eirini Zacharopoulou, Laurent Peyrin-Biroulet, Silvio Danese
  Expert Review of Gastroenterology & Hepatology.2020; 14(9): 807.     CrossRef
• Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis
  Hyuk Yoon, Sushrut Jangi, Parambir S. Dulai, Brigid S. Boland, Larry J. Prokop, Vipul Jairath, Brian G. Feagan, William J. Sandborn, Siddharth Singh
  Gastroenterology.2020; 159(4): 1262.     CrossRef
• Assessing Severity of Disease in Patients with Ulcerative Colitis
  Baldeep Singh Pabla, David Allen Schwartz
  Gastroenterology Clinics of North America.2020; 49(4): 671.     CrossRef
• Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
  Ajit Sood, Vineet Ahuja, Vandana Midha, Saroj Kant Sinha, C. Ganesh Pai, Saurabh Kedia, Varun Mehta, Sawan Bopanna, Philip Abraham, Rupa Banerjee, Shobna Bhatia, Karmabir Chakravartty, Sunil Dadhich, Devendra Desai, Manisha Dwivedi, Bhabhadev Goswami, Kir
  Intestinal Research.2020; 18(4): 355.     CrossRef
• ‘Treat to Target’ in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy
  Arianna Dal Buono, Giulia Roda, Marjorie Argollo, Kristine Paridaens, Laurent Peyrin-Biroulet, Silvio Danese
  Current Drug Targets.2020; 22(1): 117.     CrossRef
• What is the role of histopathology in the evaluation of disease activity in Crohn’s Disease?
  Rish K. Pai, Vipul Jairath
  Best Practice & Research Clinical Gastroenterology.2019;[Epub]     CrossRef
• Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis
  Lieven Pouillon, Hélène Rousseau, Hélène Busby-Venner, Marcelo De Carvalho Bittencourt, Myriam Choukour, Guillaume Gauchotte, Camille Zallot, Silvio Danese, Cédric Baumann, Laurent Peyrin-Biroulet
  Journal of Crohn's and Colitis.2019; 13(8): 970.     CrossRef
• Prediction of treatment outcome and relapse in inflammatory bowel disease
  Jun Kato, Takeichi Yoshida, Sakiko Hiraoka
  Expert Review of Clinical Immunology.2019; 15(6): 667.     CrossRef
• Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study
  Ajit Sood, Ramit Mahajan, Arshdeep Singh, Vandana Midha, Varun Mehta, Vikram Narang, Tarundeep Singh, Anmol Singh Pannu
  Journal of Crohn's and Colitis.2019; 13(10): 1311.     CrossRef
• Mucosal healing in inflammatory bowel disease: Expanding horizon
  Jimil Shah, Manik Lal Thakur, Usha Dutta
  Indian Journal of Gastroenterology.2019; 38(2): 98.     CrossRef
• A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review
  Ryan Ungaro, Jean-Frédéric Colombel, Trevor Lissoos, Laurent Peyrin-Biroulet
  American Journal of Gastroenterology.2019; 114(6): 874.     CrossRef
• A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials
  Katherine Li, Richard Strauss, Colleen Marano, Linda E Greenbaum, Joshua R Friedman, Laurent Peyrin-Biroulet, Carrie Brodmerkel, Gert De Hertogh
  Journal of Crohn's and Colitis.2019; 13(8): 1025.     CrossRef
• Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?
  Olga Maria Nardone, Rosanna Cannatelli, Davide Zardo, Subrata Ghosh, Iacucci Marietta
  Therapeutic Advances in Gastroenterology.2019;[Epub]     CrossRef
• The emerging role of histologic disease activity assessment in ulcerative colitis
  Rish K. Pai, Vipul Jairath, Niels Vande Casteele, Florian Rieder, Claire E. Parker, Gregory Y. Lauwers
  Gastrointestinal Endoscopy.2018; 88(6): 887.     CrossRef
• Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis
  Natalia Schneider Nunes, Saejeong Kim, Maggie Sundby, Parwathy Chandran, Scott Robert Burks, Ana Helena Paz, Joseph Alan Frank
  World Journal of Gastroenterology.2018; 24(38): 4341.     CrossRef
• Can histologic remission be a better prognostic factor and therapeutic target beyond endoscopic mucosal healing in patients with ulcerative colitis?
  Hyo Jun Ahn, Sang-Bum Kang
  Intestinal Research.2018; 16(1): 1.     CrossRef